Condition
Locally Advanced or Metastatic Breast Cancer clinical trials and research
As of November 12, 2026, Find a Trial lists 7 Locally Advanced or Metastatic Breast Cancer clinical trials that are recruiting, in China. By phase: Phase 3 (3), Phase 2/3 (2), Phase 2 (1). The most active sponsors are Shanghai Pharmaceuticals Holding Co., Ltd (2), MediLink Therapeutics (Suzhou) Co., Ltd. (2). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 7Clinical trials
- 1Country
Newest Locally Advanced or Metastatic Breast Cancer clinical trials
All recruiting trials (7)
-
Can compression or ice gloves and socks reduce neuropathy from UTD1 in advanced breast cancer
This randomized phase III trial tests whether compression gloves/socks or ice gloves/socks can reduce nerve problems in women with advanced breast cancer undergoing UTD1 treatment.
-
YL202 vs physician's choice in HR+/HER2- breast cancer
This trial tests YL202 against a physician's choice of approved drugs in people with HR+/HER2- breast cancer that has spread or cannot be surgically removed and who have had at least one prior chemotherapy.
-
HRS-8080 plus dalpiciclib versus fulvestrant plus dalpiciclib for advanced or metastatic breast cancer after adjuvant endocrine therapy resistance
This trial tests whether adding the new drug HRS-8080 to dalpiciclib works better than fulvestrant with dalpiciclib for people with advanced or metastatic breast cancer that became resistant to prior adjuvant hormonal therapy.
-
Evaluating YL202 for advanced breast cancer treatment
This study is testing a new treatment called YL202 for people with advanced breast cancer who haven't had success with other therapies and can't have surgery or radiation.
-
Using SPH4336 with hormone therapy for advanced breast cancer
This study is testing a new treatment called SPH4336 combined with hormone therapy to see if it helps people with advanced breast cancer that hasn't responded to other treatments.
-
New treatment for advanced breast cancer using SPH4336 and letrozole
This study is testing if a new treatment combining SPH4336 with letrozole can help women with advanced breast cancer feel better compared to just taking letrozole with a placebo.
-
Comparing utidelone and docetaxel for advanced breast cancer
This study is testing whether a new drug called utidelone works better than docetaxel for women with advanced breast cancer that is HER2-negative.
Related topics
Quick answers
How many Locally Advanced or Metastatic Breast Cancer clinical trials are recruiting right now?
7, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
All of them have sites in China. Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 3: 3, Phase 2/3: 2, Phase 2: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.